Free Trial
NASDAQ:CBLL

CeriBell (CBLL) Stock Price, News & Analysis

CeriBell logo
$12.91 +0.33 (+2.62%)
Closing price 04:00 PM Eastern
Extended Trading
$13.05 +0.14 (+1.08%)
As of 05:46 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

About CeriBell Stock (NASDAQ:CBLL)

Key Stats

Today's Range
$12.68
$13.29
50-Day Range
$12.58
$19.65
52-Week Range
$10.01
$32.75
Volume
629,190 shs
Average Volume
289,733 shs
Market Capitalization
$466.57 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$32.14
Consensus Rating
Buy

Company Overview

CeriBell Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
57th Percentile Overall Score

CBLL MarketRank™: 

CeriBell scored higher than 57% of companies evaluated by MarketBeat, and ranked 419th out of 923 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    CeriBell has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 8 buy ratings, no hold ratings, and no sell ratings.

  • Amount of Analyst Coverage

    CeriBell has only been the subject of 1 research reports in the past 90 days.

  • Read more about CeriBell's stock forecast and price target.
  • Earnings Growth

    Earnings for CeriBell are expected to grow in the coming year, from ($2.46) to ($1.18) per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of CeriBell is -4.32, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of CeriBell is -4.32, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Book Value per Share Ratio

    CeriBell has a P/B Ratio of 2.71. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

  • Short Interest

    There is no current short interest data available for CBLL.
  • Dividend Yield

    CeriBell does not currently pay a dividend.

  • Dividend Growth

    CeriBell does not have a long track record of dividend growth.

  • Short Interest

    There is no current short interest data available for CBLL.
  • News Sentiment

    CeriBell has a news sentiment score of 0.78. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.38 average news sentiment score of Medical companies.
  • News Coverage This Week

    MarketBeat has tracked 11 news articles for CeriBell this week, compared to 3 articles on an average week.
  • Search Interest

    1 people have searched for CBLL on MarketBeat in the last 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, CeriBell insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $1,965,261.00 in company stock.

  • Percentage Held by Insiders

    20.10% of the stock of CeriBell is held by insiders. A high percentage of insider ownership can be a sign of company health.

  • Read more about CeriBell's insider trading history.
Receive CBLL Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for CeriBell and its competitors with MarketBeat's FREE daily newsletter.

CBLL Stock News Headlines

CeriBell, Inc. (CBLL) Q2 2025 Earnings Call Transcript
Protect Your Bank Account with THESE 4 Simple Steps
Starting as soon as a few months from now, the United States government will make a sweeping change to bank accounts nationwide. It will give them unprecedented powers to control your bank account.
Ceribell reports Q2 EPS (38c), consensus (40c)
Ceribell Reports Second Quarter 2025 Financial Results
See More Headlines

CBLL Stock Analysis - Frequently Asked Questions

CeriBell's stock was trading at $25.88 at the beginning of 2025. Since then, CBLL shares have decreased by 50.1% and is now trading at $12.91.

CeriBell, Inc. (NASDAQ:CBLL) issued its earnings results on Tuesday, August, 5th. The company reported ($0.38) earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.40) by $0.02. The company earned $21.20 million during the quarter, compared to analysts' expectations of $20.52 million. CeriBell had a negative trailing twelve-month return on equity of 48.42% and a negative net margin of 63.83%.
Read the conference call transcript
.

CeriBell (CBLL) raised $180 million in an initial public offering on Friday, October 11th 2024. The company issued 10,606,060 shares at $17.00 per share.

CeriBell's top institutional investors include TimesSquare Capital Management LLC (2.21%), Geode Capital Management LLC (1.24%), Peregrine Capital Management LLC (0.95%) and Emerald Advisers LLC (0.35%). Insiders that own company stock include Xingjuan Chao and Rebecca B Robertson.
View institutional ownership trends
.

Shares of CBLL stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Company Calendar

Last Earnings
8/05/2025
Today
8/08/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
MED PRODUCTS
Sub-Industry
Medical Equipment
Current Symbol
NASDAQ:CBLL
Previous Symbol
NASDAQ:CBLL
CIK
1861107
Web
N/A
Fax
N/A
Employees
N/A
Year Founded
N/A

Price Target and Rating

High Price Target
$36.00
Low Price Target
$30.00
Potential Upside/Downside
+149.0%
Consensus Rating
Buy
Rating Score (0-4)
3.00
Research Coverage
8 Analysts

Profitability

EPS (Trailing Twelve Months)
($2.99)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$40.46 million
Net Margins
-63.83%
Pretax Margin
-63.83%
Return on Equity
-48.42%
Return on Assets
-28.50%

Debt

Debt-to-Equity Ratio
0.11
Current Ratio
13.31
Quick Ratio
16.81

Sales & Book Value

Annual Sales
$65.44 million
Price / Sales
7.13
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$4.76 per share
Price / Book
2.71

Miscellaneous

Outstanding Shares
36,140,000
Free Float
28,878,000
Market Cap
$466.57 million
Optionable
N/A
Beta
N/A

Social Links

 The Best Nuclear Energy Stocks to Buy Cover

Nuclear energy stocks are roaring. It's the hottest energy sector of the year. Cameco Corp, Paladin Energy, and BWX Technologies were all up more than 40% in 2024. The biggest market moves could still be ahead of us, and there are seven nuclear energy stocks that could rise much higher in the next several months. To unlock these tickers, enter your email address below.

Get This Free Report

This page (NASDAQ:CBLL) was last updated on 8/8/2025 by MarketBeat.com Staff
From Our Partners